169 related articles for article (PubMed ID: 2445959)
1. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the metabolism of striatal dynorphin by the dopaminergic system.
Li SJ; Sivam SP; McGinty JF; Jiang HK; Douglass J; Calavetta L; Hong JS
J Pharmacol Exp Ther; 1988 Jul; 246(1):403-8. PubMed ID: 2899169
[TBL] [Abstract][Full Text] [Related]
3. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
Sivam SP; Krause JE; Takeuchi K; Li S; McGinty JF; Hong JS
J Pharmacol Exp Ther; 1989 Mar; 248(3):1297-301. PubMed ID: 2467980
[TBL] [Abstract][Full Text] [Related]
4. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
[TBL] [Abstract][Full Text] [Related]
5. Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats.
Sivam SP; Krause JE
J Pharmacol Exp Ther; 1990 Aug; 254(2):433-9. PubMed ID: 1696630
[TBL] [Abstract][Full Text] [Related]
6. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
Sivam SP
J Pharmacol Exp Ther; 1989 Sep; 250(3):818-24. PubMed ID: 2476548
[TBL] [Abstract][Full Text] [Related]
7. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
Ritter JK; Schmidt CJ; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1984 May; 229(2):487-92. PubMed ID: 6201607
[TBL] [Abstract][Full Text] [Related]
8. Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists.
Bannon MJ; Elliott PJ; Bunney EB
Brain Res; 1987 Dec; 427(1):31-7. PubMed ID: 2448008
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system.
Li S; Sivam SP; Hong JS
Brain Res; 1986 Nov; 398(2):390-2. PubMed ID: 2879611
[TBL] [Abstract][Full Text] [Related]
10. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.
Li SJ; Jiang HK; Stachowiak MS; Hudson PM; Owyang V; Nanry K; Tilson HA; Hong JS
Brain Res Mol Brain Res; 1990 Aug; 8(3):219-25. PubMed ID: 1977070
[TBL] [Abstract][Full Text] [Related]
11. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
12. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons.
Bannon MJ; Lee JM; Giraud P; Young A; Affolter HU; Bonner TI
J Biol Chem; 1986 May; 261(15):6640-2. PubMed ID: 2422168
[TBL] [Abstract][Full Text] [Related]
13. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
Zeng BY; Jenner P; Marsden CD
Mov Disord; 1996 Jan; 11(1):43-52. PubMed ID: 8771066
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.
Hanson GR; Alphs L; Wolf W; Levine R; Lovenberg W
J Pharmacol Exp Ther; 1981 Aug; 218(2):568-74. PubMed ID: 6166743
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
Sivam SP
Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
[TBL] [Abstract][Full Text] [Related]
16. Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol.
Sivam SP; Strunk C; Smith DR; Hong JS
Mol Pharmacol; 1986 Aug; 30(2):186-91. PubMed ID: 3016502
[TBL] [Abstract][Full Text] [Related]
17. Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain.
Chesselet MF; Weiss L; Wuenschell C; Tobin AJ; Affolter HU
J Comp Neurol; 1987 Aug; 262(1):125-40. PubMed ID: 2887596
[TBL] [Abstract][Full Text] [Related]
18. Effects of lithium and haloperidol administration on the rat brain levels of substance P.
Hong JS; Tilson HA; Yoshikawa K
J Pharmacol Exp Ther; 1983 Mar; 224(3):590-3. PubMed ID: 6186804
[TBL] [Abstract][Full Text] [Related]
19. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
20. The serotoninergic bulbospinal system and brainstem-spinal cord content of serotonin-, TRH-, and substance P-like immunoreactivity in the aged rat with special reference to the spinal cord motor nucleus.
Johnson H; Ulfhake B; Dagerlind A; Bennett GW; Fone KC; Hökfelt T
Synapse; 1993 Sep; 15(1):63-89. PubMed ID: 7508641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
